Skip to main content
. 2021 Sep 21;15:1292. doi: 10.3332/ecancer.2021.1292

Table 3. Adverse events.

Toxicity Grade 1–2, n (%) Grade 3–4, n = 22 (37%)
Anaemia 20 (34%) 6 (10%)
Thrombocytopenia 14 (24%) 4 (6%)
Febrile neutropenia 2 (3%) 4 (6%)
Diarrhoea 16 (28%) 8 (13%)
Neuropathy 12 (20%) 5 (9%)
Hand foot syndrome 24 (41%) 6 (10%)
Hypersensitivity 3 (5%) 1 (2%)